Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ESTRADIOL NOVARTIS (estradiol)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ESTRADIOL NOVARTIS (estradiol)

Medicine - Posted on Jun 26 2002 - Updated on Jun 12 2019
Active substance (DCI)
  • estradiol
history (2)
  • 6/26/02

    ESTRADIOL NOVARTIS 37,5 µg/24 h, dispositif transdermique ESTRADIOL NOVARTIS 50 µg/24 h, dispositif transdermique ESTRADIOL NOVARTIS 75 µg/24 h, dispositif transdermique ESTRADIOL NOVARTIS 100 µg/24 h, dispositif transdermique boite de 8 (estradiol)

    ESTRADIOL NOVARTIS 37,5 µg/24 h, dispositif transdermique ESTRADIOL NOVARTIS 50 µg/24 h, dispositif transdermique ESTRADIOL NOVARTIS 75 µg/24 h, dispositif transdermique ESTRADIOL NOVARTIS 100 µg/24 h, dispositif transdermique boite de 8 (estradiol)
    icône flèche
  • 6/26/02

    ESTRADIOL G GAM (estradiol)

    ESTRADIOL G GAM (estradiol)
    icône flèche
Technical information
ATC code
  • G03CA03
Manufacturer
NOVARTIS S.A.
Presentation

ESTRADIOL G GAM 37,5 mg/24 h, dispositif transdermique

ESTRADIOL G GAM 75 mg/24 h, dispositif transdermique
boîte de 8

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
M1aR7u8uHYyff5QQ